Sproutly Canada Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Arup Sen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.7yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.3yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Nov 30 2021 | n/a | n/a | -CA$14m |
| Aug 31 2021 | n/a | n/a | -CA$13m |
| May 31 2021 | n/a | n/a | -CA$15m |
| Feb 28 2021 | CA$100k | CA$100k | -CA$16m |
| Nov 30 2020 | n/a | n/a | -CA$59m |
| Aug 31 2020 | n/a | n/a | -CA$59m |
| May 31 2020 | n/a | n/a | -CA$61m |
| Feb 29 2020 | CA$182k | CA$182k | -CA$62m |
| Nov 30 2019 | n/a | n/a | -CA$12m |
| Aug 31 2019 | n/a | n/a | -CA$12m |
| May 31 2019 | n/a | n/a | -CA$14m |
| Feb 28 2019 | CA$121k | CA$121k | -CA$13m |
Compensation vs Market: Insufficient data to establish whether Arup's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Arup's compensation with company performance.
CEO
Arup Sen
5.7yrs
Tenure
CA$100,000
Compensation
Dr. Arup Sen, PhD has been Chief Executive Officer at Sproutly Canada Inc. since May 14, 2020 and serves as it's Chairman since August, 2020. Dr. Sen serves as the Chief Executive Officer of Infusion Biosc...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 5.7yrs | CA$100.00k | no data | |
| Corporate Secretary & Director | 3.8yrs | CA$102.40k | no data | |
| Independent Director | 4.7yrs | no data | no data | |
| Independent Director | 3.8yrs | no data | no data |
4.3yrs
Average Tenure
Experienced Board: SRUT.F's board of directors are considered experienced (4.3 years average tenure).